Intrinsic-fluorescence binding to full-length PPARα
Biochemical assay · Purified full-length, untagged recombinant human and mouse PPARα [1]
Clofibrate quenched intrinsic receptor fluorescence; rosiglitazone showed no determinable binding. Reported Kd values are biochemical affinity estimates, not cellular EC50 values.
| Endpoint | Reported result | Reference |
|---|---|---|
| Clofibrate binding to human PPARα | Kd 58 ± 6 nM (mean ± SE; n ≥ 3) | [1] |
| Clofibrate binding to mouse PPARα | Kd 39 ± 6 nM (mean ± SE; n ≥ 3) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Increasing clofibrate concentrations; receptor concentration 0.1 μM
- Method
- Intrinsic aromatic amino acid fluorescence quenching at 24°C; excitation 280 nm; background and inner-filter correction
- Reported limits
- Incubation duration and clofibrate vehicle not specified in the selected quenching method. No independent chemical analysis of clofibrate reported in the read material.
Methods and source locations
Compound reported in the paper: Clofibrate; Compound label in the paper: Clofibrate as named by the authors; no Adooq lot validation
Reported experimental clofibrate only; conditions and responses are model specific.
Methods: Chemicals, recombinant protein purification, intrinsic-fluorescence quenching; Results; Tables 1–2; Figures 1, 3K/L, 4K/L
Clofibrate binding to human PPARα: Intrinsic receptor fluorescence quenching — Table 1 clofibrate row and footnote; Figure 3K and caption
Clofibrate binding to mouse PPARα: Intrinsic receptor fluorescence quenching — Table 2 clofibrate row and footnote; Figure 4K and caption